FDA

Citing Heart Problems, FDA Calls For Limiting Use Of Antimalarial Drugs Trump Championed
By | April 24, 2020 12:22 p.m.
A Top Government Scientist Sends A Sharp Warning About ‘Politicized’ COVID-19 Work
By | April 23, 2020 5:17 p.m.
FDA Commissioner: ‘Too Early’ To Say Whether Economy Should Reopen In May
By | April 12, 2020 1:55 p.m.
NANTONG, CHINA - FEBRUARY 27 2020: Employees work on the production line of chloroquine phosphate, resumed after a 15-year break, in a pharmaceutical company in Nantong city in east China's Jiangsu province Thursday, Feb. 27, 2020. Chloroquine phosphate, an old drug for the treatment of malaria, has shown some efficacy and acceptable safety against COVID-19 associated pneumonia in trials, according to Chinese media. FDA Gives Emergency Authorization To Potential COVID-19 Drugs, But Doubts Remain
By | March 30, 2020 6:07 p.m.
The Bucks Stops Over There Somewhere: Trump Refuses To Own COVID-19 Failures
By | March 13, 2020 5:43 p.m.
Head Of National Cancer Institute Will Temporarily Take Over FDA
By | March 12, 2019 2:57 p.m.
FDA Commissioner Resigns After Nearly Two Years Leading Agency
By | March 5, 2019 3:32 p.m.
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Deputy Editor:
Investigations Desk:
Reporters:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: